Ronald Caputo, MD
Cardiovascular Disease · Naples, FLNPI 1063408227
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Cardiva Medical, Inc. at 38.6% of the total. Reporting peaked in 2024 at $23,239 and has fallen 51.0% since, to $11,382 in 2025. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $286.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiva Medical, Inc.$32K
- Medtronic$26K
- Merit Medical Systems Inc$6K
- Opsens Inc.$4K
- Cordis US CORP.$3K
- Cardinal Health 200 LLC$3K
- plus $9K from 34 others
Across 83 payments — averaging $15,567 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1M
- Abbott$162K
- Cardiva Medical, Inc.$90K
- Boehringer Ingelheim$17K
- Amarin Pharma, Inc.$8K
- Boston Scientific$401
What the payments were for
- Consulting fees$48,68858%
- Speaking & faculty fees$21,77526%
- Grants$160%
- Travel & lodging$4,8606%
- Food & beverage$8,01210%
- Education$40%
- Entertainment$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiva Medical, Inc. | 21 | $32,165 |
| Medtronic(2 entities) | 44 | $25,721 |
| Merit Medical Systems Inc | 2 | $6,052 |
| Opsens Inc. | 4 | $4,020 |
| Cordis US CORP. | 7 | $3,442 |
| Cardinal Health 200 LLC | 5 | $3,393 |
| Terumo Medical Corporation | 7 | $1,420 |
| Edwards Lifesciences | 19 | $1,349 |
| Inari Medical, Inc. | 19 | $1,125 |
| Boston Scientific | 32 | $792 |
| Siemens Medical Solutions USA, Inc. | 2 | $500 |
| Bard Peripheral Vascular, Inc. | 1 | $500 |
| Novartis | 15 | $276 |
| ZOLL Circulation Inc | 1 | $231 |
| Abbott | 9 | $218 |
| Johnson & Johnson | 11 | $208 |
| Abiomed | 7 | $200 |
| Amgen | 12 | $192 |
| Pfizer | 9 | $161 |
| Boehringer Ingelheim | 8 | $149 |
| Merck | 7 | $141 |
| Acist Medical Systems, Inc. | 6 | $127 |
| Sanofi | 1 | $125 |
| Stryker | 5 | $123 |
| AstraZeneca | 7 | $115 |
| Penumbra, Inc. | 5 | $101 |
| Alnylam Pharmaceuticals Inc. | 5 | $100 |
| Biotronik Inc. | 2 | $76 |
| Silk Road Medical, Inc. | 1 | $59 |
| Cvrx, Inc. | 4 | $58 |
| Impulse Dynamics (USA) Inc. | 1 | $42 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $37 |
| W. L. Gore & Associates, Inc. | 1 | $24 |
| Teleflex LLC | 1 | $24 |
| Cook Medical LLC | 1 | $16 |
| Biosense Webster, Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $15 |
| Livanova USA, Inc. | 1 | $14 |
| Cardiovascular Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SavvyWire$44,000
- Resolute$23,539
- OptoWire$9,000
- Wrapsody Stent Graft$6,000
- Optitorque$1,200
- Heartrail$1,200
- TR Band$1,200
- Glidesheath$1,200
- CoreValve Evolut$1,196
- FLOWTRIEVER CATHETER, S$912
- CT THROMBECTOMY SYSTEM KIT$912
- MYNX CONTROL$900
- SUPER TORQUE$563
- RAIN SHEATH TRANSRADIAL$563
- Infiniti$563
- RAILWAY$563
- CorPath GRX$500
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$383
- TherOx DS2 Console$231
- Catheter$231
How this compares
$83,375 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 90 | $112,564 |
| JardianceEmpagliflozin | 23 | $37,006 |
| Repatha SureclickEvolocumab | 36 | $36,948 |
| EntrestoSacubitril/Valsartan | 20 | $33,823 |
| Repatha SyringeEvolocumab | 11 | $8,533 |
| Prasugrel Hcl | 78 | $6,051 |
| ClopidogrelClopidogrel Bisulfate | 279 | $3,941 |
| Metoprolol Succinate | 117 | $1,559 |
| Rosuvastatin Calcium | 115 | $1,503 |
| Losartan Potassium | 99 | $1,098 |
| Atorvastatin Calcium | 108 | $986 |
| Valsartan | 20 | $840 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 33 | $642 |
| Amlodipine Besylate | 60 | $559 |
| Carvedilol | 47 | $377 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $161 | $112,56490 claims |
| Boehringer IngelheimJardiance | $149 | $37,00623 claims |
| NovartisEntresto | $276 | $33,82320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Naples
- William OneillNaples$637K
- Dee Dee WangNaples$173K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.